The introduction of USP <232>and ICH Q3D has required the pharmaceutical industry to re-evaluate how elemental impurity (heavy metal) is performed. USP <735>and EP 2.2.37 enable the use of X-ray fluorescence (XRF) spectrometry for this analysis.

In this webinar, the capabilities of the Epsilon 4, the new Malvern Panalytical benchtop XRF system, to analyze elemental impurities according to USP <232>and ICH Q3D will be demonstrated.